M06
Conditions
Interventions
Group 1: Patients with rheumatoid arthritis undergoing routine therapy with quarterly outpatient appointments for progress assessment over an entire period of one year:
1) clinical examination with jo
Sponsors
Helios Fachklinik Vogelsang Klinik für Rheumatologie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Age >18 years, m/f/d - For patients diagnosed with RA or for control participants (rheumatic disease, but no RA or symptomatic for diagnostic clarification without evidence of rheumatic disease) - Consent to participate in the study and the resulting data collection and processing - Ability to understand the patient information and willingness to sign the informed consent form
Exclusion criteria
Exclusion criteria: - Psychiatric illness that restricts understanding of the study protocol (unable to give informed consent) - Taking antibiotics at the start of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Under close monitoring and AI-supported data analysis, new biomarkers and tools can be identified that indicate RA disease activity or an increase in RA disease activity at an early stage. | — |
Secondary
| Measure | Time frame |
|---|---|
| Immunological biomarkers indicate early treatment failure with an increase in disease activity. | — |
Countries
Germany
Contacts
Public ContactMonika Brunner-Weinzierl
Universitätsklinik Magdeburg, Experimentelle Pädiatrie
Outcome results
None listed